Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 May;43(3):494-504.
doi: 10.1111/opo.13115. Epub 2023 Mar 7.

Myopia control in Mendelian forms of myopia

Emilie van der Sande  1   2   3 , Jan Roelof Polling  1   2   4 , J Willem L Tideman  1   2   5 , Magda A Meester-Smoor  1   2 , Alberta A H J Thiadens  1 , Emily Tan  1 , Chris I De Zeeuw  3   6 , Ralph Hamelink  3   7 , Ingo Willuhn  3   7 , Virginie J M Verhoeven  1   8 , Beerend H J Winkelman  1   3   6 , Caroline C W Klaver  1   2   9   10
Affiliations

Myopia control in Mendelian forms of myopia

Emilie van der Sande et al. Ophthalmic Physiol Opt. 2023 May.

Abstract

Purpose: To study the effectiveness of high-dose atropine for reducing eye growth in Mendelian myopia in children and mice.

Methods: We studied the effect of high-dose atropine in children with progressive myopia with and without a monogenetic cause. Children were matched for age and axial length (AL) in their first year of treatment. We considered annual AL progression rate as the outcome and compared rates with percentile charts of an untreated general population. We treated C57BL/6J mice featuring the myopic phenotype of Donnai-Barrow syndrome by selective inactivation of Lrp2 knock out (KO) and control mice (CTRL) daily with 1% atropine in the left eye and saline in the right eye, from postnatal days 30-56. Ocular biometry was measured using spectral-domain optical coherence tomography. Retinal dopamine (DA) and 3,4-dihydroxyphenylacetic acid (DOPAC) were measured using high-performance liquid chromatography.

Results: Children with a Mendelian form of myopia had average baseline spherical equivalent (SE) -7.6 ± 2.5D and AL 25.8 ± 0.3 mm; children with non-Mendelian myopia had average SE -7.3 ± 2.9 D and AL 25.6 ± 0.9 mm. During atropine treatment, the annual AL progression rate was 0.37 ± 0.08 and 0.39 ± 0.05 mm in the Mendelian myopes and non-Mendelian myopes, respectively. Compared with progression rates of untreated general population (0.47 mm/year), atropine reduced AL progression with 27% in Mendelian myopes and 23% in non-Mendelian myopes. Atropine significantly reduced AL growth in both KO and CTRL mice (male, KO: -40 ± 15; CTRL: -42 ± 10; female, KO: -53 ± 15; CTRL: -62 ± 3 μm). The DA and DOPAC levels 2 and 24 h after atropine treatment were slightly, albeit non-significantly, elevated.

Conclusions: High-dose atropine had the same effect on AL in high myopic children with and without a known monogenetic cause. In mice featuring a severe form of Mendelian myopia, atropine reduced AL progression. This suggests that atropine can reduce myopia progression even in the presence of a strong monogenic driver.

Keywords: Mendelian myopia; atropine; dopamine; lipoprotein receptor-related protein 2 knockout mouse; myopia control; syndromic myopia.

PubMed Disclaimer

References

REFERENCES

    1. Tideman JWL, Snabel MCC, Tedja MS, van Rijn GA, Wong KT, Kuijpers RWAM, et al. Association of axial length with risk of uncorrectable visual impairment for Europeans with myopia. JAMA Ophthalmol. 2016;134:1355-63.
    1. Hysi PG, Choquet H, Khawaja AP, Wojciechowski R, Tedja MS, Yin J, et al. Meta-analysis of 542,934 subjects of European ancestry identifies new genes and mechanisms predisposing to refractive error and myopia. Nat Genet. 2020;52:401-7.
    1. Tedja MS, Wojciechowski R, Hysi PG, Eriksson N, Furlotte NA, Verhoeven VJM, et al. Genome-wide association meta-analysis highlights light-induced signaling as a driver for refractive error. Nat Genet. 2018;50:834-48.
    1. Li J, Zhang Q. Insight into the molecular genetics of myopia. Mol Vis. 2017;23:1048-80.
    1. Tedja MS, Haarman AEG, Meester-Smoor MA, Kaprio J, Mackey DA, Guggenheim JA, et al. IMI - myopia genetics report. Invest Ophthalmol Vis Sci. 2019;60:M89-105.

Publication types

LinkOut - more resources